IMNN · Healthcare · $5M
$1.34-3.26%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 463 Biotechnology peers
“OVATION III 환자 등록 속도가 계획보다 약 67% 빠른 시험기관당 월 0.5명으로, 과거 난소암 임상시험 평균 월 0.2명도 크게 웃돌”
In the company's words · 2026 2분기 earnings call